Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Nov 17;26:100138. doi: 10.1016/j.jecr.2022.100138

Role of the immune system and possible mechanisms in COVID-19 vaccine-induced thyroiditis: Case report and literature review

Vahid Reisi-Vanani a, Mahour Farzan a, Mahan Farzan a, Hosein Ataei-Goujani a, Maryam Keihani b, Golshan Taghipour-Boroujeni c,
PMCID: PMC9671674  PMID: 36415601

Abstract

Introduction

Subacute thyroiditis (SAT) is an inflammatory disease that has different trigger factors. Recent studies show the possible role of COVID-19 vaccine-induced thyroiditis in its initiation. Herein we report the first case of post-Sputnik V vaccination SAT.

Case presentation

A 42-year-old man without any specific disease was admitted due to tremors, palpation and sweating, and neck tenderness on the thyroid gland. Laboratory markers and radiologic assessments highlighted thyroiditis for him, and his symptoms were relieved by administering NSAIDs and corticosteroids.

Discussion

There are several hypotheses for the etiology of post-COVID-19 immunization SAT; among them, immunologic reactions like the interactivity of human proteome with viral components and autoimmune/inflammatory syndrome induced by adjuvants (ASIA) are more probable than other discussed possibilities. We suggest further studies to discover the exact SAT pathophysiology to prevent the underlying causes among future vaccine candidates.

Keywords: Subacute thyroiditis, SARS-CoV-2, COVID-19, Vaccine, Case report, Autoimmune/inflammatory syndrome induced by adjuvants/ASIA syndrome

1. Introduction

Subacute thyroiditis (SAT) is a rare inflammatory disorder that causes symptoms like thyrotoxicosis and throat tenderness. It usually occurs 1–2 weeks following viral infection. Difficulties in SAT diagnosis are due to its nonspecific clinical symptoms and self-limiting feature [1]. Patients with SAT can develop symptoms of hyperthyroidism, hypothyroidism, and complete recovery may even last several months. Untreated SATs can precede permanent complications. Since SAT is strongly associated with viral infections, an increase in SAT incidence seems possible during this COVID-19 pandemia [2]. Viruses are the leading cause of this condition, and adenovirus, enterovirus, coxsackievirus, mumps, measles, and recently coronaviruses had been reported to cause thyroiditis as thyroid cells could express angiotensin-converting enzyme-2 (ACE-2) receptors that might facilitate direct invasion of coronavirus to it [3]. To our knowledge, there are few reported cases of SAT following Sputnik V vaccination, and a review of literature on post-COVID-19 immunization SAT.

2. Case presentation

A 42-year-old man presented to the clinic with neck pain and swelling, difficulty in swallowing, occasional hot flashes, palpitation, tremors, fatigue, and malaise. He got the first dose of COVID-19 Sputnik V seven days before the initiation of his symptoms; He also did not have any past medical history and was infected with severe acute respiratory syndrome coronavirus 2 six months ago that was treated in outpatient settings. After the first dose administration, he felt symptoms like fatigue, fever and chills, sore throat, and myalgia persisting for about two days. Due to the COVID-19 pandemia, COVID-19 RT-PCR was done with a negative result for this virus and had tried to treat his symptoms with antihistamines and antibiotics without any consultation with a physician. Since his symptoms did not get better, he presented to a clinic 20 days after the initiation of symptoms. He also refused to inject the second dose of the vaccine. Since he had been participating in a study investigating post-vaccination antibody response (Ethic code: IR.SKUMS.REC.1400.090), his serum had been collected and stored before injection of the first vaccine dose. Sample analysis after the diagnosis of SAT revealed subclinical hypothyroidism for him before the administration of the vaccine. Because of his clinical signs and symptoms like neck tenderness on the thyroid gland, sweating, tremor, and palpation, laboratory (Table 1 ) and radiological assessments were conducted for him, including thyroid function tests and thyroid ultrasound. Thyroid ultrasound showed mild enlargement of the thyroid gland with hypoechoic and heterogenic parenchyma in favor of acute thyroiditis. The radiologist also reported a hyper echo, well-defined solid nodule about 5.5 mm2 in the upper part of the left lobe. Naproxen 750 mg/day and prednisolone 12 mg/day was prescribed for him for one week and was tapered in 4 weeks. As his thyroid function tests were in their normal range, levothyroxine had not been prescribed, and he did not use beta-blockers for his symptoms in the course of his disease.

Table 1.

Laboratory data of patient. First, second and third blood sample were gathered before vaccine injection, 23 days, and six month after the only vaccine dose.

Test 1st sample 2nd sample 3rd sample Reference
T3 1.43 3.99 1.51 1.3–3.4 nmol/L
T4 83 271.6 88 66–180 nmol/L
TSH 5.18 0.1 3.50 0.25–5 mIU/mL
Anti-TPO 11.5 14.4 Positive: >40 IU/mL
Anti-TG 13.2 13.5 Normal: < 115 IU/mL
Anti-Spike antibody 26.3 100≥ Positive: ≥ 8
RU/mL
Negative: <8
WBC 12300 4000–12000
Neutrophil 8856
Lymphocyte 2091
Mix% 1353
ESR 1h 71 Normal: <15
CRP ++

T3 Triiodothyronine, T4 thyroxine, TSH thyroid-stimulating hormone, Anti-TPO Anti-thyroid Peroxidase Antibody, Anti-TG Antithyroglobulin antibody, WBC white blood cells, ESR erythrocyte sedimentation rate, CRP C-reactive protein.

3. Discussion

Subacute thyroiditis is a transient inflammation of the thyroid gland that occurs about 12/10000 per year in the United States. Its absolute etiology is still unknown, but epidemiological studies suggest an association between viral infections and its occurrence. Thyrotoxicosis symptoms besides neck tenderness and thyroid gland enlargement direct physicians to this diagnosis. Although a transient increase in anti-TPO antibody titer might occur during its course, other anti-thyroid antibodies are usually absent in this disease, and physicians screen TSH, fT4 (and sometimes fT3) in suspected patients [4]. Besides its self-limiting characteristic, some life-threatening adverse events especially due to thyrotoxicosis, including cardiac arrhythmias could occur, making its diagnosis, treatment, and follow-up important [5].

SAT occurrence after the COVID-19 infection made researchers mention the coronavirus in the group of viruses that could trigger SAT [6]. There are many theories about its etiology including: the direct invasion of the virus to the thyroid cells through ACE-2 and transmembrane protease serine 2 (TMPRSS2) receptors, inflammatory mechanisms, and even autoimmunity with viral components mimicking human proteome [7]. Besides COVID-19 infection, its vaccine can also be associated with SAT with several possible mechanisms. Autoimmune and immune-mediated reactions are one of the underlying theories. Reports of autoimmune hepatitis, type 1 diabetes mellitus, and Graves' disease after COVID-19 vaccination raised the possibility of immune-mediated mechanisms [[8], [9], [10], [11], [12]]. One probable reason is the cross-reactivity of the human proteome with virus components like spike protein, nucleoprotein, and membrane protein [13] which are the main target of vaccines. Sputnik V and other similar vaccines can trigger the immune system to produce IgG1 monoclonal antibodies against the spike of the virus that has cross-reactivity with TPO, thyroglobulin, and other cellular components of the thyroid gland [14], structural similarities between antibodies induced by vaccine and human tissue antigens are demonstrated in a study [15], that might be the triggering point for post-vaccination autoimmunity. The presented case was infected with COVID-19, and his anti-spike antibody titer was positive before vaccination. Although he had injected just the first dose of vaccine, his high antibody titer could explain somehow the relationship between vaccine-induced antibody and following SAT.

Another immune-mediated reaction that can induce autoimmune disease, especially endocrinopathies, is autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Many autoimmune disorders have been reported with vaccines using adjuvants in their ingredients to increase the efficacy of immunization; These substances can disturb immunoregulatory checkpoints, lead to polyclonal stimulation of B lymphocytes which affects T lymphocytes besides disturbance of regulatory cells that can trigger the production of viral-induced antibodies with the ability of binding to endogenous proteins for their molecular similarities. Hashimoto's thyroiditis, Graves' disease, primary ovarian failure, and type 1 diabetes mellitus have been reported after several vaccine adjuvants [16]. Many researchers suggest the role of ASIA in post-COVID-19 immunization thyroiditis [13,14,17] besides other endocrinopathies after vaccination like hypophysitis [18]. Although ASIA seems to justify these disturbances, many controversies about the duration of post-vaccination disease, especially in acute thyroiditis, suggest modifying the diagnosis criteria of ASIA [19] and investigating more accurate studies on it.

Recent studies show an association between SAT and the presence of HLA-B*35, HLA-B*18:01, DRB1*01, and C*04:01 which demonstrates the genetic susceptibility of patients that can also affect their duration and type of treatment [20,21]. Unlike chronic thyroiditis which involves both cellular and humoral immunity, cytotoxic T cells play a significant role in SAT pathogenesis by recognizing the viral and thyroid cell antigens and inducing transient inflammation [22].

There are many reports of SAT after COVID-19 immunization that usually occurred 4–7 days after the injection, as is demonstrated in Table 2 [13] which is consistent with our case and would help its diagnosis if physicians know the characteristic of post-vaccination thyroiditis.

Table 2.

Clinical manifestation and medication of sub-acute thyroiditis followed by COVID-19 vaccination.

S* Age/Sex Vaccine PMH vaccination to SAT SAT sign and Symptoms Medication S Age/Sex Vaccine PMH vaccination to SAT SAT sign and Symptoms Medication
[24] 67/M* CoronaVac®(Sinovac Life Sciences, Beijing) HTN* 17 days after 2nd dose Hypertension, Weight loss, Fever, Mild pain in anterior neck and left ear, minimal tenderness in the thyroid palpation Lercanidipine
Paracetamol
ibuprofen
[23] 55/F AstraZeneca(ChAdOx1 nCoV-19 vaccine) well-controlled asthma 3 weeks after 1st dose Neck pain and swelling for 4 weeks, headache, sore throat, myalgia, and palpitations Propranolol
Ibuprofen
Paracetamol
Levothyroxine
[26] 34/F* COVAXIN(The Bharat BiotechCOVID-19Vaccine) No PMH* 5th-7th day post vaccination Intermittentmild fever, palpitation and radiating anterior neck pain, thyroid gland enlargement and tender prednisolone [25] 38/F CoronaVac®(Sinovac Life Sciences, Beijing) No PMH 2 weeks after the second dose swelling in the neck, pain, fatigue, loss of appetite and sweating, stage 2 goitre, tenderness over the right thyroid lobe Naproxen sodium
Propranolol
Levothyroxine
[28] 42/F Pfizer/BioNTech No PMH 5 days after first dose sore throat and palpitationsheart rate in the 130swith sinus tachycardia on EKG Ibuprofen [27] 51/F
39/F
Pfizer/BioNTech
AstraZeneca(ChAdOx1 nCoV-19 vaccine)
No PMH
No PMH
4 days after receiving the first dose
3 weeks
nausea, mild anterior neck pain and fever up to 38,2 °C tender in thyroid gland on palpation Methylprednisolone No special treatment
Prednisone
Propranolol
[29] 26/F
49/F
Vaxzervria (AstraZeneca; Sweden)
Spikevax(Moderna Biotech, Spain)
No PMH
Benign thyroid nodules
2 weeks after the first dose
2 weeks after the first dose
Cervical pain that radiated to both ears, fever and chills, tenderness in the thyroid
Sore throat, headaches and difficulty in concentrating, right cervical pain radiating to the ear
Ibuprofen
Prednisolone
Ibuprofen
Diclofenac
Prednisolone
[30] 75/M AstraZeneca (ChAdOx1, Vaxzervria). No significant
PMH
14 days headache, fever, neck pain and tenderness, shortness of breath, intermittent palpitations, insomnia and anxiety, tachycardia Ibuprofen
[13] 35/F
34/F
37/F
CoronaVac®(Sinovac Life Sciences, Beijing)
(CoronaVac®, Sinovac Life Sciences, Beijing)
(CoronaVac®, Sinovac Life Sciences, Beijing)
No PMH
Covid-19
No PMH
4 days after the second dose
4 days after first dose
7 days after the second dose
Severe sore throat, palpitation, fever, fatigue,
sensitive, painful, and enlarged thyroid gland
anterior neck pain, fatigue, weight loss,
palpitations, myalgia
mild anterior neck pain, mild tenderness over the right lobe of the thyroid gland, palpated, sensitive and enlarged right lobe of thyroid (at 4th week)
Paracetamol
Methylprednisolone
Propranolol
Methylprednisolone
Propranolol
Paracetamol
[31] 57/F Pfizer/BioNTech No PMH 34 days after first dose
13 days after second dose
progressive anterior
neck pain and swelling, fever (38.3), right thyroid gland enlargement with diffuse tenderness
Propranolol
Ibuprofen
Prednisone
[14] middle-aged/F Pfizer/BioNTech No PMH 2 weeks after the second dose Poor sleep, worsening night sweats, hyper defecation, weight loss, neck pain, swelling, and tenderness NSAID*
[32] 46/F Moderna mRNA-1273 SARS-CoV-2 migraine 32 days after the first dose and immediately after the second dose A tender, swollen area with increased warmth and firm consistency was noted on the anterior neck Dexamethasone
Propranolol
methylprednisolone
[33] 42/F Moderna mRNA COVID-19 vaccine Colon cancer 6 days after second dose bilateral ear pain right-sided and then left-sided earache radiating down to the lateral and anterior neck and bilateral lower jaw, ear pain was exacerbated by turning her head, swallowing, and coughing, anterior neck swelling NSAID 35 46/F
73/F
34/F
33/M
AstraZeneca
AstraZeneca
Janssen(Johnson & Johnson)
Janssen(Johnson & Johnson)
No PMH
No PMH
No PMH
No PMH
1 day after first dose
14 days after second dose
14 days after the vaccine
10 days after the vaccine
Chest pain
Dyspnea
Weight loss
Dyspnea
Weight loss
Palpitation
Both leg weakness
Not mentioned
Not mentioned
Not mentioned
Not mentioned
[34] 40/F
28/F
Pfizer/BioNTech
Pfizer/BioNTech
Covid-19
HTN
Infertility
No PMH
2 days after the vaccine
3 days after the vaccine
Nausea, vomiting, fatigue, insomnia, palpitations, fine distal tremors, increased stretch reflexes, and arhythmic heart sounds
Anxiety, insomnia, palpitations, and a distal tremor
Propranolol
Diltiazem
Ivabradine
Thiamazole
Propranolol
Thiamazole
Our case 42/M Sputnik V(Gam-COVID-Vac) Covid-19 6 months ago 7 days after first dose Neck pain, swelling, difficulty in swallowing, occasional hot flashes, palpation, tremor, fatigue, and malaise Naproxen
Prednisolone
[35] 39/F AstraZeneca No PMH 4 days after second dose Neck pain
Fever
Neck pain
Fever
Neck pain
Not mentioned
73/F AstraZeneca No PMH 11 days after first dose Not mentioned
39/M Janssen(Johnson & Johnson) No PMH 14 days after the vaccine Not mentioned

S study, F female, M male, PMH past medical history, HTN hypertension, NSAID nonsteroidal anti-inflammatory drug, SAT subacute thyroiditis.

Discussing mentioned hypothesis for the etiology of post-COVID-19 immunization SAT, the possibility that the onset of SAT after the vaccine could be just a mere coincidence should be pointed out. If AISA has stronger evidence, administration of a different vaccine with different adjuvants would diminish the possibility of thyroiditis after booster doses. Finally, we suggest more studies on the underlying mechanisms.

Patient Consent

Written informed consent was obtained from the patient for publication of this case report.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.Bostan H., Sencar M.E., Calapkulu M., Hepsen S., Duger H., Unsal I.O., et al. Two important issues in subacute thyroiditis management: delayed diagnosis and inappropriate use of antibiotics. European Thyroid Journal. 2021:1–7. doi: 10.1159/000513745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Görges J., Ulrich J., Keck C., Müller-Wieland D., Diederich S., Janssen O.E. Long-term outcome of subacute thyroiditis. Exp Clin Endocrinol Diabetes. 2020;128(11):703–708. doi: 10.1055/a-0998-8035. [DOI] [PubMed] [Google Scholar]
  • 3.Coperchini F., Ricci G., Croce L., Denegri M., Ruggiero R., Villani L., et al. Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study. Endocrine. 2021;74(3):638–645. doi: 10.1007/s12020-021-02807-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Reismann P. Subacute (de Quervain's) thyroiditis. Pract. Clin. Endocrinol. 2021:171–177. [Google Scholar]
  • 5.Brancatella A., Ricci D., Cappellani D., Viola N., Sgrò D., Santini F., et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab. 2020;105(10):e3742–e3746. doi: 10.1210/clinem/dgaa537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ruggeri R.M., Campennì A., Siracusa M., Frazzetto G., Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Basel) 2021;20(1):219–221. doi: 10.1007/s42000-020-00230-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Siolos A., Gartzonika K., Tigas S. Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabolism open. 2021 doi: 10.1016/j.metop.2021.100136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bril F., Al Diffalha S., Dean M., Fettig D.M. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol. 2021;75(1):222–224. doi: 10.1016/j.jhep.2021.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ghielmetti M., Schaufelberger H.D., Mieli-Vergani G., Cerny A., Dayer E., Vergani D., et al. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity? J Autoimmun. 2021;123 doi: 10.1016/j.jaut.2021.102706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Vuille-Lessard É., Montani M., Bosch J., Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021;123 doi: 10.1016/j.jaut.2021.102710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Two cases of graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid. 2021;31(9):1436–1439. doi: 10.1089/thy.2021.0142. [DOI] [PubMed] [Google Scholar]
  • 12.Patrizio A., Ferrari S.M., Antonelli A., Fallahi P. A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125 doi: 10.1016/j.jaut.2021.102738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.İremli B.G., Şendur S.N., Ünlütürk U. Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: post-vaccination ASIA syndrome. J Clin Endocrinol Metab. 2021 doi: 10.1210/clinem/dgab373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jeeyavudeen M.S., Patrick A.W., Gibb F.W., Dover A.R. COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis. BMJ Case Reports CP. 2021;14(11) doi: 10.1136/bcr-2021-246425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vojdani A., Vojdani E., Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2021;11:3679. doi: 10.3389/fimmu.2020.617089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Watad A., David P., Brown S., Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front Endocrinol. 2017;7:150. doi: 10.3389/fendo.2016.00150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Das L., Bhadada S., Sood A. Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis. J Endocrinol Invest. 2021:1–3. doi: 10.1007/s40618-021-01681-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Murvelashvili N., Tessnow A. A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine. J Invest Med High Impact Case Rep. 2021;9 doi: 10.1177/23247096211043386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shoenfeld Y., Agmon-Levin N. ‘ASIA’–autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8. doi: 10.1016/j.jaut.2010.07.003. [DOI] [PubMed] [Google Scholar]
  • 20.Stasiak M., Tymoniuk B., Michalak R., Stasiak B., Kowalski M.L., Lewiński A. Subacute thyroiditis is associated with HLA-B* 18: 01,-DRB1* 01 and-C* 04: 01—the significance of the new molecular background. J Clin Med. 2020;9(2):534. doi: 10.3390/jcm9020534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Stasiak M., Tymoniuk B., Stasiak B., Lewiński A. The risk of recurrence of subacute thyroiditis is HLA-dependent. Int J Mol Sci. 2019;20(5):1089. doi: 10.3390/ijms20051089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kojima M., Nakamura S., Oyama T., Sugihara S., Sakata N., Masawa N. Cellular composition of subacute thyroiditis. an immunohistochemical study of six cases. Pathol Res Pract. 2002;198(12):833–837. doi: 10.1078/0344-0338-00344. [DOI] [PubMed] [Google Scholar]
  • 23.Oyibo S.O. Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19) Cureus. 2021;13(6) doi: 10.7759/cureus.16045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Şahin Tekin M., Şaylısoy S., Yorulmaz G. Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccines Immunother. 2021:1–3. doi: 10.1080/21645515.2021.1947102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Saygılı E.S., Karakilic E. Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Reports CP. 2021;14(10) doi: 10.1136/bcr-2021-244711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Soltanpoor P., Norouzi G. Subacute thyroiditis following COVID‐19 vaccination. Clin Case Rep. 2021;9(10) doi: 10.1002/ccr3.4812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Siolos A., Gartzonika K., Tigas S. Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabolism open. 2021;12 doi: 10.1016/j.metop.2021.100136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bahl S., Babu P.M., Capatana F., Khan I., Adlan M., Premawardhana L.D. Sub-acute thyroiditis presenting as pyrexia of uknown origin. J Endocr. Soc. 2021;5(Supplement_1):A956–A. [Google Scholar]
  • 29.Bornemann C., Woyk K., Bouter C. Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med. 2021;8 doi: 10.3389/fmed.2021.737142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ratnayake G.M., Dworakowska D., Grossman A.B. Can COVID‐19 immunisation cause subacute thyroiditis? Clin Endocrinol. 2021 doi: 10.1111/cen.14555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Schimmel J., Alba E.L., Chen A., Russell M., Srinath R. Letter to the editor: thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine. Thyroid. 2021;31(9):1440. doi: 10.1089/thy.2021.0184. [DOI] [PubMed] [Google Scholar]
  • 32.Patel M., Shahid M., Khawaja A., Ejike C., Vemuri K. Subacute thyroiditis secondary to moderna COVID-19 vaccine: a case report of a rare manifestation. Adv Clin Med Res Healthc Deliv. 2021;1(2):9. [Google Scholar]
  • 33.Plaza-Enriquez L., Khatiwada P., Sanchez-Valenzuela M., Sikha A. A case report of subacute thyroiditis following mRNA COVID-19 vaccine. Case Rep Endocrinol. 2021 doi: 10.1155/2021/8952048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Vera-Lastra O., Ordinola Navarro A., Cruz Domiguez M.P., Medina G., Sánchez Valadez T.I., Jara L.J. Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid. 2021 doi: 10.1089/thy.2021.0142. [DOI] [PubMed] [Google Scholar]
  • 35.Lee K., Kim Y.J., Jin H.Y. Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine. 2021;74(3):470–472. doi: 10.1007/s12020-021-02898-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical and Translational Endocrinology Case Reports are provided here courtesy of Elsevier

RESOURCES